101 related articles for article (PubMed ID: 12606674)
1. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.
Loher F; Schmall K; Freytag P; Landauer N; Hallwachs R; Bauer C; Siegmund B; Rieder F; Lehr HA; Dauer M; Kapp JF; Endres S; Eigler A
J Pharmacol Exp Ther; 2003 May; 305(2):549-56. PubMed ID: 12606674
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
3. Adenosine kinase inhibitor GP515 improves experimental colitis in mice.
Siegmund B; Rieder F; Albrich S; Wolf K; Bidlingmaier C; Firestein GS; Boyle D; Lehr HA; Loher F; Hartmann G; Endres S; Eigler A
J Pharmacol Exp Ther; 2001 Jan; 296(1):99-105. PubMed ID: 11123368
[TBL] [Abstract][Full Text] [Related]
4. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice.
Hartmann G; Bidlingmaier C; Siegmund B; Albrich S; Schulze J; Tschoep K; Eigler A; Lehr HA; Endres S
J Pharmacol Exp Ther; 2000 Jan; 292(1):22-30. PubMed ID: 10604928
[TBL] [Abstract][Full Text] [Related]
5. A novel mTOR inhibitor is efficacious in a murine model of colitis.
Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
7. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
[TBL] [Abstract][Full Text] [Related]
9. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
10. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Katada K; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Watabe J; Yoshida N; Okanoue T; Yoshikawa T
J Nutr Biochem; 2006 Jun; 17(6):402-9. PubMed ID: 16214331
[TBL] [Abstract][Full Text] [Related]
11. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
12. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
13. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
Yamamoto S; Sugahara S; Naito R; Ichikawa A; Ikeda K; Yamada T; Shimizu Y
Eur J Pharmacol; 2006 Jul; 541(1-2):106-14. PubMed ID: 16780833
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
15. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
18. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
19. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
20. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Martín AR; Villegas I; Alarcón de la Lastra C
Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]